Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bispectral-Electroencephalography (EEG) in First Time Hemodialysis

NCT: NCT03276273 · RECRUITING

NCT IDNCT03276273
StatusRECRUITING
Start Date2017-05-01
Completion2027-12-01

Brief Summary

The severity of minimal dialysis disequilibrium syndrome (DDS) is currently detected and graded clinically using clinical criteria. Bispectral Index (BIS), an electroencephalographic (EEG) derived parameter is widely used in anesthesia and Critical Care setting to detect effects of anesthetic/hypnotic drugs. The aim of our study was to assess the discriminative power of BIS monitoring to accurately detect DDS.

Frequently Asked Questions

What is Bispectral-Electroencephalography (EEG) in First Time Hemodialysis?

Bispectral-Electroencephalography (EEG) in First Time Hemodialysis is a clinical trial registered under NCT03276273. Current status: RECRUITING.

What is the status of NCT03276273?

The current status of NCT03276273 (Bispectral-Electroencephalography (EEG) in First Time Hemodialysis) is: RECRUITING.

When did Bispectral-Electroencephalography (EEG) in First Time Hemodialysis start?

Bispectral-Electroencephalography (EEG) in First Time Hemodialysis started on 2017-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑